Skip to main content
Erschienen in: BMC Musculoskeletal Disorders 1/2019

Open Access 01.12.2019 | Case report

Charcot neuroarthropathy of the knee due to idiopathic sensory peripheral neuropathy

verfasst von: Qian-Hao Yang, Peichun Hsu, You-Shui Gao, Chang-Qing Zhang

Erschienen in: BMC Musculoskeletal Disorders | Ausgabe 1/2019

Abstract

Background

Charcot neuroarthropathy is a systemic disease that generates pathological changes in the musculoskeletal system, causing instability, dislocations, and deformities. Charcot neuroarthropathy of the knee, due to either diabetes mellitus or syringomyelia, is anecdotally reported with the epidemic of the diseases. However, idiopathic sensory peripheral neuropathy can inflict osteoarticular structures directly, inducing a dysfunctional Charcot neuroarthropathy. An early diagnosis and effective relief of the symptomatic deformity is essential for the treatment.

Case presentation

We report the case of a patient with idiopathic sensory peripheral neuropathy who presented with a swelling right knee, as well as distorted and painless gait disorder, diagnosed as Charcot neuroarthropathy of the knee. Partial weight bearing with a hinged knee brace was used to correct the abnormal alignment and gait posture, and bisphosphonates were prescribed to decrease pathological bone resorption. Although the alignment and Knee Society Score got a gradual deterioration, the combination of orthosis and pharmacy could alleviate the symptom to a certain extent.

Conclusion

The diagnosis of Charcot neuroarthropathy of the knee is rare that requiring early diagnosis. The presence of features, including painlessness, numbness, and deformed arthropathy following chronic-onset algesthesia loss should be taken carefully.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ALP
Alkaline phosphatase
FTA
Femorotibial angle
KSS
Knee Society Score
TKA
Total knee arthroplasty

Background

Charcot neuroarthropathy is a systemic disease that generates pathological changes in the musculoskeletal system, causing instability, dislocations, and deformities [1], first named by Jean Martin Charcot (1829–1893) in 1868 [2]. Diabetes mellitus and neurosyphilis are the most common causes of Charcot neuroarthropathy these days, mostly affecting the foot and ankle [3].
Charcot neuroarthropathy is reported to be closely associated with diabetes mellitus [4], syringomyelia [5], neurosyphilis [2], and idiopathic neuropathy [6], which might be misdiagnosed in many cases. With an increasing incidence of arthropathy, there is controversy about the treatment of Charcot neuroarthropathy in the knee. Total knee arthroplasty (TKA), arthrodesis, and conservative treatment should be considered appropriately in Charcot neuroarthropathy of diverse causes and stages. In the scenario of concomitant osteomyelitis, amputation might become the treatment of choice [7]. Herein, we present a case of Charcot neuroarthropathy of the knee following idiopathic sensory peripheral neuropathy.

Case presentation

A 40-year-old man presented to the orthopedic clinic with a 2-week history of swelling in the right knee and a 1-year history of painless gait disorder. He had previously been diagnosed with idiopathic sensory peripheral neuropathy, for which he had multiple fingertips falling off in his early teens and left leg amputation 5 years prior following massive painless ulceration (Fig. 1). The diagnosis of idiopathic sensory peripheral neuropathy follows the approach to the evaluation of peripheral neuropathies [8], evidenced as the unique clinical manifestation of distally predominant and symmetrical sensory abnormalities, and electrophysiological findings of mainly axonal damage. Charcot-Marie-Tooth disease was excluded due to his normal motor function. There was no history of diabetes mellitus and neurosyphilis. He also had no family history of inherited diseases.
On physical examination, a valgus distortion of the knee was noted, with significantly restricted ranges of flexion (105°) and extension (10°). Inspired by a recent study [9], we used the system of Knee Society Score (KSS) to evaluate the function. The knee score was 46 and the function score was 40 on admission. There was a slight deep tenderness over the superolateral aspect of the patella and the lateral femoral condyle. Despite gross deformity and distinct instability, he complained of no pain during daily activities and sleep. Paracentesis yielded bloody effusions, both negative for biochemical examinations and microbial culture. Laboratory studies showed slight elevation in alkaline phosphatase (ALP) levels (147 U/L; reference: 34-104 U/L) at admission, reflecting abnormal absorption of bone metabolism. Infection was excluded due to the normal ranges of leukocyte count (4.7 × 109/L; reference: 3.5 × 109–9.5 × 109/L), C-reactive protein (10.36 mg/L; reference: 0.00–10.00 mg/L), and erythrocyte sedimentation rate (12 mm/h; reference: 0–21 mm/h) along with negative microbiological and cytological examination of the repeated fluid aspiration. The coagulation and syphilis tests were normal without evidence of hemophilic arthritis and syphilis-induced Charcot arthropathy. Plain radiographs and CT scans showed apparent widening of the joint space and multiple abrasions of the lateral femoral condyle, with abnormal debris close to the posterior plateau (Figs. 2, 3). Stress radiography was not conducted due to the high risk of pathologic fractures and incompetency of pain complaint. Plain radiographs, captured under supine and neutral position, showed the femorotibial angle (FTA) was 165°. Magnetic resonance imaging revealed a wide impairment of the anterior cruciate ligament, lateral collateral ligament, and meniscus lateralis with massive joint effusions (Fig. 4). Idiopathic sensory peripheral neuropathy-induced Charcot neuroarthropathy was diagnosed in collaboration with neurologists.
Partial weight bearing with a hinged knee brace was advocated to correct the abnormal alignment and gait posture, followed by a gradual increase in flexion and extension over a 3-month period for clinical improvement. However, the significant disability determined the joint motion should be protected by the orthosis. Mild swelling of the knee was found in the lateral compartment, but there was no tenderness or redness. Additionally, he was administered physical therapy and rehabilitation along with bisphosphonates to decrease pathological bone resorption. ALP was dynamically monitored and found to be maintained between 108~134 U/L (reference: 50–136 U/L). Plain radiographs at the 12-month follow-up showed the valgus knee with the FTA of 159°, with a slight deterioration restricted in the lateral compartment (Fig. 5). The knee was reevaluated with KSS, showing the knee score dropped to 41 and the function score maintained 40. The range of motion was 10°~ 105°, reflecting the flexion and extension in the sagittal plane was not affected. Considering the potential risks of arthroplasty and inherent disadvantages of arthrodesis, protected weightbearing with the orthosis was recommended as the current treatment of choice [10].

Discussion and conclusions

Historically, the 2 dominant pathophysiological causes of Charcot neuroarthropathy included the neurotraumatic (abnormal sensory innervation, repeated microtrauma, and unregulated inflammatory cascade) and neurovascular theories (hypervascular region in subchondral bone, vascular shunting, and subsequent osteopenia) [1, 3]. Peripheral neuropathy caused by diabetes mellitus is the main cause of Charcot neuroarthropathy of the knee. While the idiopathic sensory peripheral neuropathy in our case can cause chronic-onset loss of algesthesia, inducing hypalgesia, numbness, and deformed arthropathy. The primary degeneration of the dorsal root ganglion and trigeminal ganglion sensory neurons can cause gait ataxia, proprioceptive sensory loss, unnoticed damage, as well as repetitive microtrauma to the weight-bearing joint, contributing to Charcot neuroarthropathy [11, 12]. If not diagnosed and intervened promptly, it may result in severe complications, such as fractures and joint dislocations.
Charcot neuroarthropathy can occur secondary to syringomyelia, syphilis, diabetic neuropathy, alcoholic peripheral neuropathy, and idiopathic neuropathy. Diabetes is the most common etiology. Charcot neuroarthropathy is considered a major risk factor for below-the-knee amputation among the diabetics [1], while upper extremity can also be affected as a result of syringomyelia [5]. The diagnosis of Charcot neuroarthropathy is based primarily on thorough history and physical examination, including features, such as loss of protective sensation, presence of ulceration, and warm, swollen, erythematous foot and/or ankle. A combination of autonomic neuropathy, motor neuropathy, and sensory neuropathy results in osteopenia, joint instability, and increased loads on joints. The signs and symptoms of idiopathic sensory peripheral neuropathy-induced Charcot neuroarthropathy are consistent with non-length dependent nerve-fiber degeneration. The loss of sensory neurons in the dorsal root ganglia induce degeneration of short and long peripheral axons and central sensory projections in the posterior columns. Idiopathic sensory peripheral neuropathy induced Charcot neuroarthropathy, unlike others, is a rare disorder with unique characteristics, including deformities of fingertips and asymmetrical sensory disturbances.
Neuropathic arthropathy can be classified into four stages using standard radiology (prodromal, developmental, coalescence, and reconstructive) [10]. Identification of Charcot neuroarthropathy of the knee in Stage 0 and I have important therapeutic implications. The immobilization and non-weight bearing of the knee may prevent progression of skeletal destruction and deformity. Antiresorptive therapy, especially with bisphosphonates, has been revealed to have a modest effect on Charcot neuroarthropathy [13], inhibiting excessive osteoclast activation and proinflammatory cytokine response [14]. Total knee arthroplasty (TKA) and arthrodesis should be employed only in the reconstruction or coalescence stages [15], similar to a salvage operative treatment. Although TKA is satisfactory for most patients [16], the complications due to fragile bone and ligamentous laxity still exists [17], including periprosthetic fracture, aseptic loosening, instability, and infection [18]. Knee arthrodesis is accompanied by major functional limitations, resulting in the restriction of knee motion. Bisphosphonates were prescribed due to the nature of progressive destruction of Charcot neuroarthropathy. Bisphosphonates were beneficial to control the level of ALP, which was monitored through the observation. However, with a brief literature review, we found most of previous studies did not detect any biomarkers associated with bone absorption [5, 6, 9, 1922]. Although Charcot neuroarthropathy is not a bone metabolism disorder in nature, a dynamic monitor of serum biomarkers can provide substantial reference to modulate bone homeostasis and alleviate skeletal destruction. The activity of osteoclast and underlying inflammation should be evidenced by essential mechanistic investigations in the future [1].
To the best of our knowledge, this is the first case of Charcot neuroarthropathy due to idiopathic sensory peripheral neuropathy. The patient had an impressive history of multiple fingertips abscission and left leg amputation following painless ulceration. Nerve conduction studies confirmed the presence of idiopathic sensory peripheral neuropathy. The swelling of the right knee and painless gait disorder were the primary clinical features, consistent with the diagnosis of neuropathic arthropathy of the knee. Moreover, only the lateral compartment of the knee was significantly involved, with an obvious valgus deformity, detected promptly before total joint destruction. Our case had satisfactory clinical outcomes from periods of nonoperative management in Stage I.
In summary, the diagnosis of Charcot neuroarthropathy of the knee is rare and is considered as the accumulated effect of peripheral neuropathy. Although an early diagnosis of Charcot arthropathy cannot alter natural course of the disease, it is beneficial to relieve symptoms and prevent severe complications. The presence of features, including painlessness, numbness, and deformed arthropathy following chronic-onset algesthesia loss increases the likelihood of idiopathic sensory peripheral neuropathy-induced Charcot neuroarthropathy.

Acknowledgements

We thank the patient for agreeing to publication of his case. Additionally, we sincerely thank Prof. You-Fen Tan from Jiangsu Provence Hospital of TCM, Prof. Yu-Pu Guo from Peking Union Hospital and Prof. Fan Liu from Nantong University Affiliated Hospital, for their contributions in the diagnosis and care of the patient. Although the disease is depressing, our patient is still filled with enthusiasm for life.
All procedures were part of the standard medical care, and the need for ethics approval and consent to participate was waived.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. The proof of consent to publish from study participants can be requested at any time.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Dodd A, Daniels TR. Charcot neuroarthropathy of the foot and ankle. J Bone Joint Surg Am. 2018;100(8):696–711.CrossRef Dodd A, Daniels TR. Charcot neuroarthropathy of the foot and ankle. J Bone Joint Surg Am. 2018;100(8):696–711.CrossRef
2.
Zurück zum Zitat Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat. 2009;23(6):409–26.CrossRef Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat. 2009;23(6):409–26.CrossRef
3.
Zurück zum Zitat Kucera T, Urban K, Sponer P. Charcot arthropathy of the knee. A case-based review. Clin Rheumatol. 2011;30(3):425–8.CrossRef Kucera T, Urban K, Sponer P. Charcot arthropathy of the knee. A case-based review. Clin Rheumatol. 2011;30(3):425–8.CrossRef
4.
Zurück zum Zitat Patel A, Saini AK, Edmonds ME, Kavarthapu V. Diabetic neuropathic arthropathy of the knee: two case reports and a review of the literature. Case Rep Orthop. 2018;2018:9301496.PubMedPubMedCentral Patel A, Saini AK, Edmonds ME, Kavarthapu V. Diabetic neuropathic arthropathy of the knee: two case reports and a review of the literature. Case Rep Orthop. 2018;2018:9301496.PubMedPubMedCentral
5.
Zurück zum Zitat Li G, Ding Y, Zhang C, Huang H. Syringomyelia with left knee Charcot arthropathy: a case report. Br J Neurosurg. 2018. p. 1–2. Li G, Ding Y, Zhang C, Huang H. Syringomyelia with left knee Charcot arthropathy: a case report. Br J Neurosurg. 2018. p. 1–2.
6.
Zurück zum Zitat Hanson LF, Hanson CG, Barner KL. Idiopathic Charcot arthropathy of the knee presenting as a Bicondylar Tibial plateau fracture. J Am Acad Orthop Surg Glob Res Rev. 2018;2(7):e032.PubMedPubMedCentral Hanson LF, Hanson CG, Barner KL. Idiopathic Charcot arthropathy of the knee presenting as a Bicondylar Tibial plateau fracture. J Am Acad Orthop Surg Glob Res Rev. 2018;2(7):e032.PubMedPubMedCentral
7.
Zurück zum Zitat Berli M, Vlachopoulos L, Leupi S, Boni T, Baltin C. Treatment of Charcot neuroarthropathy and osteomyelitis of the same foot: a retrospective cohort study. BMC Musculoskelet Disord. 2017;18(1):460.CrossRef Berli M, Vlachopoulos L, Leupi S, Boni T, Baltin C. Treatment of Charcot neuroarthropathy and osteomyelitis of the same foot: a retrospective cohort study. BMC Musculoskelet Disord. 2017;18(1):460.CrossRef
8.
Zurück zum Zitat England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004;363(9427):2151–61.CrossRef England JD, Asbury AK. Peripheral neuropathy. Lancet. 2004;363(9427):2151–61.CrossRef
9.
Zurück zum Zitat Tibbo ME, Chalmers BP, Berry DJ, Pagnano MW, Lewallen DG, Abdel MP. Primary total knee arthroplasty in patients with neuropathic (Charcot) arthropathy: contemporary results. J Arthroplast. 2018;33(9):2815–20.CrossRef Tibbo ME, Chalmers BP, Berry DJ, Pagnano MW, Lewallen DG, Abdel MP. Primary total knee arthroplasty in patients with neuropathic (Charcot) arthropathy: contemporary results. J Arthroplast. 2018;33(9):2815–20.CrossRef
10.
Zurück zum Zitat Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473(3):1168–71.CrossRef Rosenbaum AJ, DiPreta JA. Classifications in brief: Eichenholtz classification of Charcot arthropathy. Clin Orthop Relat Res. 2015;473(3):1168–71.CrossRef
11.
Zurück zum Zitat Sghirlanzoni A, Pareyson D, Lauria G. Sensory neuron diseases. Lancet Neurol. 2005;4(6):349–61.CrossRef Sghirlanzoni A, Pareyson D, Lauria G. Sensory neuron diseases. Lancet Neurol. 2005;4(6):349–61.CrossRef
12.
Zurück zum Zitat Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol. 2015;72(12):1510–8.CrossRef Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy: a review. JAMA Neurol. 2015;72(12):1510–8.CrossRef
13.
Zurück zum Zitat Pitocco D, Ruotolo V, Caputo S, Mancini L, Collina CM, Manto A, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28(5):1214–5.CrossRef Pitocco D, Ruotolo V, Caputo S, Mancini L, Collina CM, Manto A, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial. Diabetes Care. 2005;28(5):1214–5.CrossRef
14.
Zurück zum Zitat Jostel A, Jude EB. Medical treatment of Charcot neuroosteoarthropathy. Clin Podiatr Med Surg. 2008;25(1):63–9 vi-vii.CrossRef Jostel A, Jude EB. Medical treatment of Charcot neuroosteoarthropathy. Clin Podiatr Med Surg. 2008;25(1):63–9 vi-vii.CrossRef
15.
Zurück zum Zitat Zeng M, Xie J, Hu Y. Total knee arthroplasty in patients with Charcot joints. Knee Surg Sports Traumatol Arthrosc. 2016;24(8):2672–7.CrossRef Zeng M, Xie J, Hu Y. Total knee arthroplasty in patients with Charcot joints. Knee Surg Sports Traumatol Arthrosc. 2016;24(8):2672–7.CrossRef
16.
Zurück zum Zitat Hayashi S, Okada T, Horita K. Bilateral TKA for Charcot arthropathy associated with multiple levels of spinal canal stenoses: a case report and review of literature. J Orthop. 2017;14(1):77–80.CrossRef Hayashi S, Okada T, Horita K. Bilateral TKA for Charcot arthropathy associated with multiple levels of spinal canal stenoses: a case report and review of literature. J Orthop. 2017;14(1):77–80.CrossRef
17.
Zurück zum Zitat Kim YH, Kim JS, Oh SW. Total knee arthroplasty in neuropathic arthropathy. J Bone Joint Surg Br. 2002;84(2):216–9.CrossRef Kim YH, Kim JS, Oh SW. Total knee arthroplasty in neuropathic arthropathy. J Bone Joint Surg Br. 2002;84(2):216–9.CrossRef
18.
Zurück zum Zitat Parvizi J, Marrs J, Morrey BF. Total knee arthroplasty for neuropathic (Charcot) joints. Clin Orthop Relat Res. 2003;416:145–50.CrossRef Parvizi J, Marrs J, Morrey BF. Total knee arthroplasty for neuropathic (Charcot) joints. Clin Orthop Relat Res. 2003;416:145–50.CrossRef
19.
Zurück zum Zitat Chalmers BP, Tibbo ME, Trousdale RT, Lewallen DG, Berry DJ, Abdel MP. Primary total hip arthroplasty for Charcot arthropathy is associated with high complications but improved clinical outcomes. J Arthroplast. 2018;33(9):2912–8.CrossRef Chalmers BP, Tibbo ME, Trousdale RT, Lewallen DG, Berry DJ, Abdel MP. Primary total hip arthroplasty for Charcot arthropathy is associated with high complications but improved clinical outcomes. J Arthroplast. 2018;33(9):2912–8.CrossRef
20.
Zurück zum Zitat Figueiredo A, Ferreira R, Alegre C, Fonseca F. Charcot osteoarthropathy of the knee secondary to neurosyphilis: a rare condition managed by a challenging arthrodesis. BMJ Case Rep. 2018;2018:bcr-2018. Figueiredo A, Ferreira R, Alegre C, Fonseca F. Charcot osteoarthropathy of the knee secondary to neurosyphilis: a rare condition managed by a challenging arthrodesis. BMJ Case Rep. 2018;2018:bcr-2018.
21.
Zurück zum Zitat Nambiar M, Onggo JR, Pai V. Neuropathic arthropathy of the shoulder joint secondary to a syringomyelia. BMJ Case Rep. 2018;11(1):e228228.CrossRef Nambiar M, Onggo JR, Pai V. Neuropathic arthropathy of the shoulder joint secondary to a syringomyelia. BMJ Case Rep. 2018;11(1):e228228.CrossRef
22.
Zurück zum Zitat Choudhury P, Mohapatra A, Kharat A, Chauhan V. Neuropathic arthropathy of the shoulder joint caused by syringomyelia: report of a rare case. BMJ Case Rep. 2019;12(3):e229494.CrossRef Choudhury P, Mohapatra A, Kharat A, Chauhan V. Neuropathic arthropathy of the shoulder joint caused by syringomyelia: report of a rare case. BMJ Case Rep. 2019;12(3):e229494.CrossRef
Metadaten
Titel
Charcot neuroarthropathy of the knee due to idiopathic sensory peripheral neuropathy
verfasst von
Qian-Hao Yang
Peichun Hsu
You-Shui Gao
Chang-Qing Zhang
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Musculoskeletal Disorders / Ausgabe 1/2019
Elektronische ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-019-2873-9

Weitere Artikel der Ausgabe 1/2019

BMC Musculoskeletal Disorders 1/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.